ACTRN12611000389909尚未招募未知
A Partial Replication and Expansion Evaluating the Effectiveness of Emotional Freedom Technique (EFT) for Food Cravings, Depression and Anxiety in Overweight and Obese Adults.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Experiencing food cravings
- •Being overweight or obese - have a Body Mass Index (BMI) of 25 or greater
排除标准
- •1) eating disorder
- •2) psychotropic medication
- •3) Diabetes
- •4) Pregnant
研究者
相似试验
已完成
不适用
Feasibility and repeatability of an incremental exercise test on the combined arm-leg (Cruiser) ergometer in patients with a lower limb amputatio10003216amputation of the lower limblower limb amputation1000594210005959NL-OMON37936niversitair Medisch Centrum Groningen30
已完成
1 期
A study of a skin patch containing two medicines (physostigmine and hyoscine) in healthy male participants to assess the blood levels of the two medicines and any associated symptoms.Potential risk of poisoning by nerve agentInjury, Occupational Diseases, PoisoningISRCTN10362655Dstl35
进行中（未招募）
不适用
A long-term extension to a randomized, double-blind, placebo-controlled, stratified, parallel-group, multicenter, dose-ranging study evaluating four oral doses of TCH346 (1.0, 2.5, 7.5 and 15mg) administered once daily in patients with Amyotrophic Lateral Sclerosis.Amyotrophic Lateral SclerosisEUCTR2004-002855-15-DEovartis Pharma Services AG480
进行中（未招募）
不适用
A long-term extension to a randomized, double-blind, placebo-controlled, stratified, parallel-group, multicenter, dose-ranging study evaluating four oral doses of TCH346 (1.0, 2.5, 7.5 and 15mg) administered once daily in patients with Amyotrophic Lateral Sclerosis.Amyotrophic Lateral SclerosisEUCTR2004-002855-15-GBovartis Pharma Services AG480
进行中（未招募）
不适用
A long term extension to a randomised, double-blind, placebo-controlled, stratified, paralle-group, multicenter, dose-ranging study evaluating four oral doses of TCH346 1.0, 2.5, 7.5 and 15 mg administered once daily in patients with Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisMedDRA version: 9.1Level: LLTClassification code 10002026Term: Amyotrophic lateral sclerosisEUCTR2004-002855-15-ITOVARTIS FARMA476